Rigel Pharmaceuticals | 10-Q:季度报表
Rigel Pharmaceuticals | 8-K:锐杰公布2024年第一季度财务业绩并提供业务最新情况
Rigel Pharmaceuticals | 8-K:重大事件
Rigel Pharmaceuticals | ARS:年度报告
Rigel Pharmaceuticals | DEFA14A:其他
Rigel Pharmaceuticals | DEF 14A:股东委托书决议
Rigel Pharmaceuticals | PRE 14A:并购重组委托声明
Rigel Pharmaceuticals | 4:持股变动声明-高管 Rojkjaer Lisa
Rigel Pharmaceuticals | 3:首次持股声明-高管 Rojkjaer Lisa
Rigel Pharmaceuticals | 8-K:锐佳公布2023年第四季度和全年财务业绩并提供业务最新情况
Rigel Pharmaceuticals | 10-K:年度报表
Rigel Pharmaceuticals | 4:持股变动声明-高管 Schorno Dean L
Rigel Pharmaceuticals | 4:持股变动声明-高管 Santos David A
Rigel Pharmaceuticals | 4:持股变动声明-高管 RODRIGUEZ RAUL R
Rigel Pharmaceuticals | 4:持股变动声明-高管 Furey Raymond J.
Rigel Pharmaceuticals | 8-K:重大事件
Rigel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(9.81%),Steven Boyd(9.81%)
Rigel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.13%)
Rigel Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Morgan Stanley(8.3%),Morgan Stanley Capital Services LLC(8.1%)
Rigel Pharmaceuticals | 4:持股变动声明-高管 Santos David A
暂无数据